Daniel Joseph Calvo

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

seqWell, Inc. operates as biotechnology company. Its products include plexWellTM 96, plexWellTM 384, plexWellTM Plus 24, and plexWell LP 384. The company was founded by Joseph Mellor and is headquartered in Beverly, MA.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

Protein Technologies, Inc. engages in the design, manufacture and supply of solid phase synthesizers. The company was founded in 1985 and is headquartered in Tucson, AZ.

seqWell, Inc. operates as biotechnology company. Its products include plexWellTM 96, plexWellTM 384, plexWellTM Plus 24, and plexWell LP 384. The company was founded by Joseph Mellor and is headquartered in Beverly, MA.

seqWell, Inc. operates as biotechnology company. Its products include plexWellTM 96, plexWellTM 384, plexWellTM Plus 24, and plexWell LP 384. The company was founded by Joseph Mellor and is headquartered in Beverly, MA.

Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden.

seqWell, Inc. operates as biotechnology company. Its products include plexWellTM 96, plexWellTM 384, plexWellTM Plus 24, and plexWell LP 384. The company was founded by Joseph Mellor and is headquartered in Beverly, MA.